Description

BSE lists Rs. 30 crore commercial paper issued by Mirae Asset Financial Services (India) Private Limited with maturity on 27 February 2026.

Summary

BSE has listed 600 units of Commercial Paper issued by Mirae Asset Financial Services (India) Private Limited on private placement basis. The securities are listed on the BSE Debt segment effective 20 October 2025 with scrip code 730421 and ISIN INE0JRU14313. The commercial papers have a face value of Rs. 5,00,000 each (total issue size Rs. 30 crore) and will mature on 27 February 2026.

Key Points

  • Issuer: Mirae Asset Financial Services (India) Private Limited
  • Security Type: Commercial Paper (privately placed)
  • Issue Size: 600 units of Rs. 5,00,000 each (Rs. 30 crore total)
  • Scrip Code: 730421
  • Scrip ID: MAFS201025
  • ISIN: INE0JRU14313
  • Credit Rating: CRISIL A1+
  • Issue Price: Rs. 4,88,007 per unit
  • Allotment Date: 20 October 2025
  • Redemption Date: 27 February 2026
  • Market Lot: 1 unit
  • Tick Size: 1 paise
  • Issuing and Paying Agent: HDFC Bank Limited

Regulatory Changes

No regulatory changes announced. This is a standard commercial paper listing notice.

Compliance Requirements

  • Trading permitted only in dematerialized form under ISIN INE0JRU14313
  • Trading allowed in standard denomination of Rs. 5 lakhs and multiples thereof
  • Minimum trading lot: 1 unit (Rs. 5,00,000)
  • Trading members should contact BSE Debt Department (022-22728352/8597/8995/5753/8915) for clarifications

Important Dates

  • Listing Date: 20 October 2025
  • Allotment Date: 20 October 2025
  • Redemption Date: 27 February 2026
  • Tenor: Approximately 130 days

Impact Assessment

This is a routine commercial paper listing with minimal market impact. The instrument is available only to institutional investors through private placement and represents short-term borrowing by Mirae Asset Financial Services. The CRISIL A1+ rating indicates high credit quality. No impact on retail investors or broader market operations.

Impact Justification

Routine commercial paper listing with no regulatory changes or market-wide impact. Standard debt instrument admission for institutional investors only.